Your SlideShare is downloading. ×
โรคปอดอักเสบจากการติดเชื้อใน
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

โรคปอดอักเสบจากการติดเชื้อใน

221

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
221
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Ventilator – associated pneumonia)
  • 2. ••••
  • 3. • 4.7-34.4 1000
  • 4. • 17 – 18.8 1000 2542 17 1000
  • 5. • Ventilator – associated pneumonia : VAP) - VAP (
  • 6. Agent Factor Host Factor Environment factor• • • • Escherichia coli , Klebsiella,Pneumoniae, • Pseudomonas • aerhginosa • ,Stenotrphomonas - • IC maltophilia - ,Acinetobacter • banmannii - ward •• • S.areus
  • 7. Host AgentEnvironmentA=AgentH=HostE=Environment
  • 8. • Host Host Agent IC ward
  • 9. Web of causation Ventilator – associated pneumonia
  • 10. - Escherichia coli, Klebsiella pneumonia, Pseudom - onas aeruginosa,Stenotroph - IC omonas maltophilia, Acinetoba cter - ward ( S.areusVentilator – associated pneumonia)
  • 11. Web of causation Ventilator – associated pneumonia• Host , Agent ,Environment Host
  • 12. Web of causation Ventilator – associatedpneumonia• Environment VAP IC word VAP VAP
  • 13. Web of causation Ventilator – associatedpneumonia• Agent escherichai coli, Klebsella pnenmonia,Pseudomonas aeruginosa ,Stenotrophomonas maltophilia,Acinetobacter S.arens
  • 14. Stage ofsusceptibility) Stage of preclinical disease) Stage of clinical disease) Stage of disability)
  • 15. Stage ofsusceptibility cilia
  • 16. • Stage of preclinical disease symptom)
  • 17. • Stage of clinical disease Infiltration)
  • 18. • Stage of disability exudates)
  • 19. • Stage of disability)
  • 20. • Hospital – wide Surveillance Proiority directed Surveillance• Hospital – wide Surveillance
  • 21. • Priority directed Surveillance
  • 22. • Verify diagnosis – Clinic – – Verify the existenceof en epidemic)
  • 23. Rapid evaluation ofepidemiologic potentialities) Common experience) Collection data) Analysis data)
  • 24. Information of hypothesis) Testing hypothesis)––
  • 25. Manage of epidemic – – – Report of theinvestigation)
  • 26. - Aseptic technique)5.

×